Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. (January 2020)

• Record Type: Journal Article
• Authors: Wagner, Anna D.; Lordick, Florian; Grabsch, Heike I.; Terashima, Masanori; Terada, Mitsumi; Yoshikawa, Takaki; Boku, Narikazu; Kataoka, Kozo; Smyth, Elizabeth C.; Mauer, Murielle; Haustermans, Karin; Moehler, Markus H.
• Is Part Of: European journal of cancer. Volume 124(2020)
• Page Start: 67
• Page End: 76
• Publication Date: 2020-01
• Subjects: EORTC -- JCOG -- Gastric -- Perioperative -- Adjuvant -- Chemotherapy -- Immunotherapy; Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/j.ejca.2019.09.006
• Languages: English
• ISSNs: 0959-8049

Abstract

Abstract: The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in the multidisciplinary management of stage II-III gastric and gastro-oesophageal junction (GEJ) cancer. We seek to outline how these challenges are addressed in current trials of both groups. Key elements of future trials of EORTC and JCOG in this indication are described, and a joint vision on how multidisciplinary research of gastric and GEJ cancer patients should be organised is outlined.